REATA PHARMACEUTICALS

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 15 Sept 2022

Owner Info

Reata Pharmaceuticals, Inc.

5320 Legacy Drive

Plano TX 75024, UNITED STATES OF AMERICA

Serial Number

2238720 filed on 10 Nov 2021

Correspondent

Andrea K. Shannon Norton Rose Fulbright US LLP

98 San Jacinto Boulevard, Suite 1100,

Austin TX 78701,

UNITED STATES OF AMERICA

REATA PHARMACEUTICALS

Classification Information

2238720

10 Nov 2021

10 Nov 2031

FIGURATIVE

12 May 2021

Status Date	Action Taken
15^th Sept 2022	Customer Amendment Made correspondence sent
15^th Sept 2022	Amendment to Address for Service Requested
23^rd Mar 2022	International Registration in Australia Protected correspondence sent
22^nd Mar 2022	IP Right Registration Published
22^nd Mar 2022	Status change to Registered/Protected
14^th Jan 2022	Application Accepted correspondence sent
13^th Jan 2022	IP Right has been Examined
13^th Jan 2022	IP Right Acceptance Published
13^th Jan 2022	Status change to Accepted
24^th Dec 2021	Awaiting examination